Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do a Molina healthcare stock analysis and talk about the risks and upside potential of MOH stock

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor06 Dec 2025, 00:38 UTC
Video preview for Friends! In this video, I'm going to do a Molina healthcare stock analysis and talk about the risks and upside potential of MOH stock
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The video presents a fundamental analysis of Molina Healthcare (MOH). It highlights Michael Burry's position, where 43% of his portfolio is dedicated to the stock. The stock has declined 47% year-to-date. The company derives 88% of its business from Medicaid, 7% from Medicare, and 5% from the Healthcare Marketplace. The analysis indicates Molina's premium revenue has grown significantly, reaching $38.6 billion in 2024 from $18.2 billion in 2020, and earnings per share has also grown from $11.23 to $20.42. The analysis notes that Molina faces challenges, including higher Medical Care Ratios (MCR), which is 92% on Medicaid. The video indicates the company is repricing its Marketplace book to reduce exposure and restore margins, aiming for a 30% rate increase. In 2026, the outlook expects approximately $14.00 in earnings per share. The management team said rate increases beyond initial assumptions create a significant earnings upside of $4.50 of earnings per share for each 100 basis point increase of MLR. This leads the presenter to believe with an average P/E ratio of 15x, that the stock will recover.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.